- Home
- BBNX vs BME Comparison
BBNX vs BME Comparison
Compare BBNX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | BME |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 547.5M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | BBNX | BME |
|---|---|---|
| Price | $10.94 | $40.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $26.22 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 36.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.99 | N/A |
| Revenue Next Year | $34.47 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.89 | $34.18 |
| 52 Week High | $32.71 | $42.74 |
Technical Indicators
Market Signals| Indicator | BBNX | BME |
|---|---|---|
| Relative Strength Index (RSI) | 25.81 | 32.70 |
| Support Level | N/A | $40.55 |
| Resistance Level | $15.53 | $42.55 |
| Average True Range (ATR) | 0.70 | 0.59 |
| MACD | 0.11 | -0.19 |
| Stochastic Oscillator | 20.75 | 13.64 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.